SecBot SecBot
144 ·Filed Jun 25, 2026

ADPT

Adaptive Biotechnologies Corp
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago SEC0001950047-26-006507
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

The filing is a routine intent-to-sell by a director; no immediate bearish signal. Monitor if larger insider sales or a cluster of filings emerge, but this standalone is not actionable.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
ADPT ▲ +32.92% at T+60d
NEUTRAL call +32.92% · α vs SPY +28.43% · entry $20.96 → $27.86
Entry = T+0 close
Jun 25, 2026
via day close
T+1d
+2.10%
call +2.10% · α +0.45%
$21.40
settled 4mo ago
T+5d
+1.10%
call +1.10% · α -1.07%
$21.19
settled 4mo ago
T+20d
+6.44%
call +6.44% · α +5.18%
$22.31
settled 3mo ago
T+60d
+32.92%
call +32.92% · α +28.43%
$27.86
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Director Michelle Griffin filed a Form 144 on June 25, 2026, indicating intent to sell 52,084 shares of Adaptive Biotechnologies (ADPT) valued at approximately $1,007,305. The shares were acquired via option exercise on the same day. This is a routine small-scale sale by a non-executive director, representing about 0.03% of market cap.

Key Facts

  • Michelle Griffin (Director) filed Form 144 to sell 52,084 shares.
  • Estimated market value: ~$1,007,305 based on ~$19.34 per share.
  • Shares acquired via exercise of stock options on 06/25/2026.
  • Sale represents ~0.032% of ADPT's $3.1B market cap.
  • Recent insider activity: 5 sells totaling $2.8M over 30 days.

Financial Impact

Up to ~$1M in potential selling pressure, negligible relative to market cap.

dilution (insignificant)

Risk Factors

  • Signals insider's desire to diversify, but limited given small size.
  • Could precede additional insider selling if broader trend emerges.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-006507
Document: 0001950047-26-006507-index.html0001950047-26-006507
Document: 0001950047-26-006507.txt0001950047-26-006507
28 reports for ADPT
Performance horizon
45% Hit rate @ T+20 5 of 11 directional calls Went positive at some point 7 of 11 best @ T+60▲ +56.41%May 5, 2026
Filters
Rows
Reports for ADPT — sortable, filterable
TypeNow
Oct 6, 2026
20d ago
144
NEUTRAL ★ 2/10
$26.28awaiting T+20—$25.51 (−2.93%)
Oct 5, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$26.90awaiting T+20—$25.51 (−5.17%)
Sep 25, 2026
4w ago
Press Release
BULLISH ★ 6/10
$29.43 $25.51▼ −13.32%▼ −11.84%$25.51 (−13.32%)
Sep 18, 2026
5w ago
Insider Cluster
BEARISH ★ 5/10
$27.86 $23.95▲ +14.03%▲ +13.13%$25.51 (+8.44%)
Aug 20, 2026
9w ago
Insider Cluster
NEUTRAL ★ 4/10
$25.99 $27.86▲ +7.20%▲ +7.72%$25.51 (−1.85%)
Aug 19, 2026
9w ago
Insider Cluster
BEARISH ★ 5/10
$25.44 $28.55▼ −12.22%▼ −12.22%$25.51 (−0.28%)
Aug 18, 2026
9w ago
144
NEUTRAL ★ 3/10
$25.49 $26.68▲ +4.67%▲ +6.19%$25.51 (+0.08%)
Aug 17, 2026
10w ago
144
BEARISH ★ 4/10
$24.56 $27.67▼ −12.66%▼ −13.97%$25.51 (−3.87%)
Jul 29, 2026
12w ago
Institutional Cluster
BEARISH ★ 4/10
$24.18 $26.44▼ −9.35%▼ −5.38%$25.51 (−5.50%)
Jul 23, 2026
13w ago
Insider Cluster
NEUTRAL ★ 4/10
$22.27 $25.99▲ +16.70%▲ +13.08%$25.51 (+14.55%)
Showing 10 of 28

US Market Status

Market Closed — Opens Wed (12h 43m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 25, 2026